Epprazole enteric-coated tablets are mainly used for the treatment of duodenal ulcers in adults, and clinical trials have shown that the drug can also be used for reflux esophagitis.
Epprazole enteric-coated tablets usually appear white or off-white after removing the coating, the common specification is 5mg, should be swallowed whole, can not be chewed or crushed, mainly used for the treatment of duodenal ulcer.
The common adverse reactions of epprazole enteric-coated tablets include diarrhea, dizziness, headache, elevated serum transaminases, rash, urticaria, low back pain, abdominal distension, chest tightness, palpitations, prolongation of menstrual period and other reactions in a few patients.
Allergic to the components of epprazole enteric-coated tablets and other benzimidazole compounds are prohibited; hepatic and renal insufficiency is prohibited; this product; for general peptic ulcer and other diseases, it is not suitable for long-term high-dose; infants and young children are prohibited, and pregnant women and lactating women should take with caution.
The drug should be used under the guidance of a professional physician, and should not be taken blindly by mouth.